Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial

Patricia M. Flynn(St. Jude Children's Research Hospital), Mae Cababasay(Cancer Research And Biostatistics), Kevin Butler(Cancer Research And Biostatistics), Dhayendre Moodley(Centre for the AIDS Programme of Research in South Africa), Raziya Bobat(Jacobi Medical Center), Devasena Gnanashanmugam(Johns Hopkins University), Teacler Nematadzira(University of Zimbabwe-University of California San Francisco), Lynda Stranix‐Chibanda(University of Zimbabwe), Sandesh Patil(M.S. Ramaiah Medical College), David E. Shapiro(Intercept Pharmaceuticals (United States)), Mandisa Nyati(Chris Hani Baragwanath Hospital), Maysseb Masenya(Perinatal HIV Research Unit), Helen B. Mulenga(Centre for Infectious Disease Research in Zambia), Tichaona Vhembo(University of Zimbabwe-University of California San Francisco), Bonus Makanani(University of Malawi), Taha E. Taha(Blantyre Institute for Community Ophthalmology), Katie McCarthy(Family Health International 360), Maxensia Owor(Makerere University), Bangini Kusakara(University of Zimbabwe-University of California San Francisco), Nahida Chakhtoura(National Institutes of Health), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Gerhard Theron(Stellenbosch University), Cornelius Mukuzunga(Lilongwe University of Agriculture and Natural Resources), Blandina T. Mmbaga(College of African Wildlife Management), Mary Glenn Fowler(Johns Hopkins University), Anna Coutsoudis(University of KwaZulu-Natal), Susan A. Fiscus(University of North Carolina at Chapel Hill)
JAIDS Journal of Acquired Immune Deficiency Syndromes
December 12, 2017
Cited by 219


Related Papers